Diabetic therapeutic effects of ethyl acetate fraction from the roots of Musa paradisiaca and seeds of Eugenia jambolana in streptozotocin-induced male diabetic rats
- PMID: 20094640
- DOI: 10.1358/mf.2009.31.9.1435645
Diabetic therapeutic effects of ethyl acetate fraction from the roots of Musa paradisiaca and seeds of Eugenia jambolana in streptozotocin-induced male diabetic rats
Abstract
The folklore medicine of primitive people has been greatly appreciated for centuries. Many researchers study the curative efficiency and mode of action of various medicinal plants. Serum glucose level, lipid profile, glucose tolerance, hepatic and muscle glycogen contents as well as the activities of hepatic hexokinase and glucose-6-phosphatase recovered significantly after oral administration of ethyl acetate fractions of Eugenia jambolana (E. jambolana) or Musa paradisiaca (M. paradisiaca) in separate (E. jambolana L.: 200 mg/kg of body weight and M. paradisiaca: 100 mg/kg of body weight) or combined form for 90 days (twice a day through gavage) to streptozotocin-induced diabetic rats. The loss in body weight of diabetic animals was reversed and serum levels of insulin as well as C-peptide, which were found to be reduced in diabetic rats, increased significantly after oral administration of the fractions. A histological study of the rats' pancreas revealed that after 90 days of oral treatment with the plant fractions in separate or combined form, the size and volume of pancreatic islets in diabetic treated rats increased significantly compared with the diabetic control group. Treatment of diabetic rats with the combined dose (300 mg/kg of body weight) of plant fractions (200 mg E. jambolana and 100 mg M. paradisiaca) was found to be more effective than treatment with the individual fraction. The doses of E. jambolana and M. paradisiaca selected for this study are the optimum antihyperglycemic doses of the plant fractions, which were determined after conducting a dose-dependent study at various dose levels (50-500 mg/kg) in our pilot experiments. The plant fractions were found to be free from metabolic toxicity. Through HPTLC finger printing, three different compounds were noted in the ethyl acetate fraction of E. jambolana L. and eight different compounds in the ethyl acetate fraction of M. paradisiaca L.
Copyright 2009 Prous Science, S.A.U. or its licensors. All rights reserved.
Similar articles
-
Effect of Eugenia Jambolana seed kernel on antioxidant defense system in streptozotocin-induced diabetes in rats.Life Sci. 2004 Oct 15;75(22):2717-31. doi: 10.1016/j.lfs.2004.08.005. Life Sci. 2004. PMID: 15369706
-
Antihyperglycemic effect of the fruit-pulp of Eugenia jambolana in experimental diabetes mellitus.J Ethnopharmacol. 2006 Apr 6;104(3):367-73. doi: 10.1016/j.jep.2005.10.033. Epub 2006 Jan 18. J Ethnopharmacol. 2006. PMID: 16386863
-
Evaluation of the hypoglycemic and anti-oxidant activities of Morinda officinalis in streptozotocin-induced diabetic rats.Singapore Med J. 2002 Feb;43(2):077-85. Singapore Med J. 2002. PMID: 11993894
-
Syzygium cumini (L.) Skeels., a novel therapeutic agent for diabetes: folk medicinal and pharmacological evidences.Complement Ther Med. 2013 Jun;21(3):232-43. doi: 10.1016/j.ctim.2013.03.004. Epub 2013 Apr 25. Complement Ther Med. 2013. PMID: 23642956 Review.
-
Anticancer, chemopreventive and radioprotective potential of black plum (Eugenia jambolana lam.).Asian Pac J Cancer Prev. 2011;12(1):3-15. Asian Pac J Cancer Prev. 2011. PMID: 21517226 Review.
Cited by
-
Role of medicinal plants in the management of diabetes mellitus: a review.3 Biotech. 2019 Jan;9(1):4. doi: 10.1007/s13205-018-1528-0. Epub 2018 Dec 12. 3 Biotech. 2019. PMID: 30555770 Free PMC article. Review.
-
Phytochemical Profile, Biological Properties, and Food Applications of the Medicinal Plant Syzygium cumini.Foods. 2022 Jan 28;11(3):378. doi: 10.3390/foods11030378. Foods. 2022. PMID: 35159528 Free PMC article. Review.
-
Protective effect of aqueous extract of seed of Psoralea corylifolia (Somraji) and seed of Trigonella foenum-graecum L. (Methi) in streptozotocin-induced diabetic rat: A comparative evaluation.Pharmacognosy Res. 2013 Oct;5(4):277-85. doi: 10.4103/0974-8490.118840. Pharmacognosy Res. 2013. PMID: 24174822 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical